1. Home
  2. LKQ vs GRFS Comparison

LKQ vs GRFS Comparison

Compare LKQ & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

SELL

Current Price

$17.63

Market Cap

5.5B

ML Signal

SELL

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.55

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKQ
GRFS
Founded
1998
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.2B
IPO Year
2003
2008

Fundamental Metrics

Financial Performance
Metric
LKQ
GRFS
Price
$17.63
$7.55
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
★ $32.13
$10.87
AVG Volume (30 Days)
★ 2.9M
459.9K
Earning Date
10-29-2026
07-28-2022
Dividend Yield
★ 5.34%
1.42%
EPS Growth
N/A
★ N/A
EPS
★ 0.84
N/A
Revenue
★ $13,651,000,000.00
N/A
Revenue This Year
N/A
$2.15
Revenue Next Year
$2.37
$6.22
P/E Ratio
$26.82
★ $18.67
Revenue Growth
N/A
★ N/A
52 Week Low
$21.17
$6.96
52 Week High
$37.13
$9.90

Technical Indicators

Market Signals
Indicator
LKQ
GRFS
Relative Strength Index (RSI) 22.85 53.23
Support Level N/A $7.33
Resistance Level $26.77 $7.68
Average True Range (ATR) 0.69 0.15
MACD -0.21 0.03
Stochastic Oscillator 7.49 67.50

Price Performance

Historical Comparison
LKQ
GRFS

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: